期刊文献+

上皮性卵巢癌生物治疗研究进展 被引量:4

下载PDF
导出
摘要 上皮性卵巢癌是第二常见的妇科恶性瘤,死亡率却居于首位。卵巢癌因缺乏有效的筛查手段故难以早期诊断,大多数病人发现时已到晚期。虽经肿瘤细胞减灭术和系统的放化疗治疗,但卵巢癌复发转移病人的5年生存率仍徘徊在40%。近年来,卵巢癌的生物学治疗取得了很多重要的进展,已经成为卵巢癌继手术治疗、化疗、放疗之后的第四种治疗模式,给卵巢癌治疗提供了新的研究方向。
作者 纪巍 王丹
出处 《临床军医杂志》 CAS 2013年第1期91-94,共4页 Clinical Journal of Medical Officers
  • 相关文献

参考文献6

  • 1Wu, C.J,Ritz, J.Induction of tumor immunity following allogeneic stem cell transplantation[].Advances in Immunology.2006
  • 2Perez EA.Cardiac toxicity of ErbB2-targeted therapies:what do we know[].Clinical Breast Cancer.2008
  • 3Evan P. Booy,Dina Johar,Srilekha Maddika,Hasan Pirzada,Mickey M. Sahib,Iris Gehrke,Shauna Loewen,Sherif F. Louis,Kamran Kadkhoda,Michael Mowat,Marek Los.Monoclonal and bispecific antibodies as novel therapeutics[J].Archivum Immunologiae et Therapiae Experimentalis.2006(2)
  • 4Rosa DD,Clamp AR,Collinson F, et al.Antiangiogenic threapy for ovarian cancer[].Current Opinion in Oncology.2007
  • 5Spannuth WA,Nick AM,Jennings NB et al.Functional significance of VEGFR-2 on ovarian cancer cells[].International Journal of Cancer.2009
  • 6J Konner,RJ Schilder,FA DeRosa,WP Tew,PJ Sabbatini,ML Hensley,DR Spriggs,CA Aghajanian.A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced ovarian, primary peritoneal, or fallopian tube cancer[].Gynecologic Oncology.2008

同被引文献55

  • 1陈川(综述),俞德超(审阅),滕理送(审阅).以VEGF/VEGFR为靶点的抗肿瘤药物的研究进展[J].中国肿瘤生物治疗杂志,2007,14(3):291-295. 被引量:25
  • 2陶厚权,王瑞年,林言箴.血管内皮生长因子与肿瘤[J].肿瘤,1997,17(1):52-54. 被引量:13
  • 3Martin L,Schilder R.Novel approaches in advancing the treatment ofepithelial ovarian cancer:the role of angiogenesis inhibition[J].J Clin Oncol, 2007,25 (20) : 2894-2901.
  • 4Olsson AK,Dimberg A,Kreuger J,et a/.VEGF receptor signalling-in control of vascular function[J].Nat Rev Mol Cell Bial,2010,7(5):359- 371.
  • 5Stylianidou A,Van'as M ,Akrivis C ,et a/.Sclerosing stromal tumor of the ovary:a case report and review of the literature[J].Eur J Gynaecol Oncol, 2001,22(4) :300-304.
  • 6Nakanishi Y, Kodama J,Yoshinouchi M,et al.The expression of vascular endothelial growth factor and transforming growth factor beta associates with angiogenesis in epithelial ovarian cancer[J].Int J Gynecol Pathol, 1997,16(3) :256-262.
  • 7Kiselyov A,Balakin KV,Tkachenko SE.VEGF/VEGFR signalling as a target for inhibiting angiogenesis[J].Expert Opin Investig Drugs,2007, 16( 1 ) : 83-107.
  • 8Jain RK.Normalization of tumor vasculature:an emerging concept in autiangiogenic therapy [J].Science ,2005,307 (5706) : 58-62.
  • 9Lohela M ,Bry M ,Tammela T,et a/.VEGFs and receptors involved in angiogenesis versus lymphangiogenesis[J].Curr Opin Cell Biol,2009, 21 (2) : 154-165.
  • 10Rudge JS,Holash J,Hyhon D,et a/.VEGF Trap complex formation measures production rates of VEGF,providing a biomarker for predicting efficacious angiogenic blockade[J].Proc Natl Acad Sci ,2007,104(47) : 18363-18370.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部